Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced

Bionano Genomics, Inc. (BNGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/17/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress"
08/04/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Bionano Genomics, Inc",
"Certificate of Elimination of Series A Preferred Stock"
07/07/2023 SC 13G/A BlackRock Inc. reports a 2% stake in Bionano Genomics, Inc
06/16/2023 4 Mamuszka Hannah (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 4 Rajkovic Aleksandar (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 4 Luderer Albert (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 4 Linney Yvonne (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/16/2023 4 Wong Vincent Jung-Fai (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 4 Vuori Kristiina MD (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 4 TWOMEY CHRISTOPHER J (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
06/16/2023 4 BARKER DAVID L (Director) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Granted 250,000 options to buy @ $0.7458, valued at $186.5k
05/16/2023 4 Holmlin R. Erik (President and CEO) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Bought 15,000 shares @ $0.6426, valued at $9.6k
05/16/2023 4 Stewart Christopher P. (CFO) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Bought 50,000 shares @ $0.6683, valued at $33.4k
05/16/2023 4 OLDAKOWSKI MARK (COO) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Paid exercise price by delivering 41,496 shares @ $0.66, valued at $27.4k
05/16/2023 4 Holmlin R. Erik (President and CEO) has filed a Form 4 on Bionano Genomics, Inc.
Txns: Paid exercise price by delivering 50,141 shares @ $0.66, valued at $33.1k
05/11/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress"
05/08/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 8-K Quarterly results
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/14/2023 8-K Quarterly results
03/13/2023 8-K Other Events  Interactive Data
03/10/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy